Previous 10 | Next 10 |
SANTA CLARA, Calif. , Feb. 19, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter of 2019 after market close o...
SI-BONE (NASDAQ: SIBN ) has priced its public offering of 4.3M common shares at $21.50 per share, ~1.8M shares from selling stockholders and ~2.5M from the company. More news on: SI-BONE, Inc., Healthcare stocks news, , Read more ...
SANTA CLARA, Calif., Jan. 22, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the pricing of its public offering of 4,300...
SI-BONE (NASDAQ: SIBN ) commences a public offering of 4.3M common shares, ~1.8M from selling stockholders and ~2.5M from the company. More news on: SI-BONE, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
SANTA CLARA, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that it has commenced an underwritten publi...
SI-BONE ( SIBN +4.3% ) expects Q4 revenues in the range of $19.5M-19.8M (+25-27% Y/Y) vs. a consensus of $18.64M. SIBN expects full year 2020 revenue to be in the range of $80M -$82M (~+19%-22%) vs. a consensus $81.46M. More news on: SI-BONE, Inc., Healthcare stocks news, ...
SANTA CLARA, Calif., Jan. 09, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced preliminary unaudited revenue for the fourth quarter and full year 2019. Prelimina...
NuVasive (NASDAQ: NUVA ) initiated with Buy rating and $93 (19% upside) price target at SunTrust. More news on: NuVasive, Inc., OrthoPediatrics Corp., PerkinElmer, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Allogene Therapeutics (NASDAQ: ALLO ) initiated with Market Perform rating and $37 (36% upside) price target at JMP Securities. More news on: Allogene Therapeutics, Inc., CorMedix, Inc., Fortress Biotech, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
SANTA CLARA, Calif., Dec. 13, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that CIGNA has established a positive coverage policy for minimally ...
News, Short Squeeze, Breakout and More Instantly...
SANTA CLARA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2024 after market close on Monday, Au...
2024-07-04 13:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-14 15:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...